688351 微电生理
已收盘 11-15 15:00:00
资讯
新帖
简况
微电生理-U大跌5.02% 6家券商给予增持建议
智选洞察 · 10-29
微电生理-U大跌5.02% 6家券商给予增持建议
浦银国际证券:给予微电生理买入评级,目标价位27.9元
证券之星 · 10-29
浦银国际证券:给予微电生理买入评级,目标价位27.9元
浦银国际证券给予微电生理买入评级,3Q24国内业务有所承压,海外业务稳健增长
每日经济新闻 · 10-29
浦银国际证券给予微电生理买入评级,3Q24国内业务有所承压,海外业务稳健增长
太平洋给予微电生理买入评级,微电生理点评报告:集采加速产品放量,脉冲消融进展顺利
每日经济新闻 · 10-28
太平洋给予微电生理买入评级,微电生理点评报告:集采加速产品放量,脉冲消融进展顺利
太平洋:给予微电生理买入评级
证券之星 · 10-28
太平洋:给予微电生理买入评级
中邮证券:给予微电生理买入评级
证券之星 · 10-25
中邮证券:给予微电生理买入评级
【机构调研记录】汇添富基金调研甘源食品、微电生理等6只个股(附名单)
证券之星 · 10-25
【机构调研记录】汇添富基金调研甘源食品、微电生理等6只个股(附名单)
【机构调研记录】新华基金调研微电生理
证券之星 · 10-25
【机构调研记录】新华基金调研微电生理
微电生理-U:配送商调整及收入延期确认影响短期业绩 高端产品放量可期
国盛证券 · 10-25
微电生理-U:配送商调整及收入延期确认影响短期业绩 高端产品放量可期
微电生理:10月22日接受机构调研,华泰证券、富国基金等多家机构参与
证券之星 · 10-24
微电生理:10月22日接受机构调研,华泰证券、富国基金等多家机构参与
微电生理-U大幅上涨 北京发布医疗器械产业提质升级行动计划
智选洞察 · 10-24
微电生理-U大幅上涨 北京发布医疗器械产业提质升级行动计划
华安证券:给予微电生理买入评级
证券之星 · 10-23
华安证券:给予微电生理买入评级
微电生理-U10月23日主力资金流入168万元 连续3日加仓
市场透视 · 10-23
微电生理-U10月23日主力资金流入168万元 连续3日加仓
微电生理(688351)2024年三季报简析:营收净利润同比双双增长,公司应收账款体量较大
证券之星 · 10-23
微电生理(688351)2024年三季报简析:营收净利润同比双双增长,公司应收账款体量较大
微电生理三季报归属净利润同比大涨262.22%,三同行业绩报喜
金色光 · 10-22
微电生理三季报归属净利润同比大涨262.22%,三同行业绩报喜
平安证券:给予微电生理增持评级
证券之星 · 10-22
平安证券:给予微电生理增持评级
图解微电生理三季报:第三季度单季净利润同比增163.92%
证券之星 · 10-22
图解微电生理三季报:第三季度单季净利润同比增163.92%
微电生理:公司业绩保持稳健增长 经营质量不断提升
平安证券 · 10-22
微电生理:公司业绩保持稳健增长 经营质量不断提升
微电生理:多项创新产品顺利推进 公司净利润端表现出色
广发证券 · 10-22
微电生理:多项创新产品顺利推进 公司净利润端表现出色
微电生理(688351.SH)发布前三季度业绩,净利润4172.67万元,同比增长262.22%
智通财经 · 10-21
微电生理(688351.SH)发布前三季度业绩,净利润4172.67万元,同比增长262.22%
公司概况
公司名称:
上海微创电生理医疗科技股份有限公司
所属行业:
专用设备制造业
上市日期:
2022-08-31
主营业务:
上海微创电生理医疗科技股份有限公司的主营业务是电生理介入诊疗与消融治疗领域创新医疗器械研发、生产和销售,提供具备全球竞争力的“以精准介入导航为核心的诊断及消融治疗一体化解决方案”。公司主要产品包括心脏电生理设备与心脏电生理耗材等。公司合计取得已授权境内外专利120项,其中发明专利69项。公司始终关注科技成果与产业应用的深度融合,先后承担了国家级和省市级科研课题17项。2022年公司获得国家级专精特新“小巨人”企业认定称号。
发行价格:
16.51
{"stockData":{"symbol":"688351","market":"SH","secType":"STK","nameCN":"微电生理","latestPrice":20.37,"timestamp":1731654000000,"preClose":20.91,"halted":0,"volume":2017649,"delay":0,"floatShares":125000000,"shares":471000000,"eps":0.0763,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.54,"latestTime":"11-15 15:00:00","open":20.79,"high":21.2,"low":20.37,"amount":41713800,"amplitude":0.0397,"askPrice":20.37,"askSize":70,"bidPrice":20.36,"bidSize":10,"shortable":0,"etf":0,"ttmEps":0.0763,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731893400000},"adr":0,"adjPreClose":20.91,"symbolType":"stock_kcb","openAndCloseTimeList":[[1731634200000,1731641400000],[1731646800000,1731654000000]],"highLimit":23,"lowLimit":18.82,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":470600000,"pbRate":5.54,"roa":"--","roe":"2.44%","epsLYR":0.0121,"committee":-0.389356,"marketValue":9586000000,"floatMarketCap":2543000000,"peRate":266.972468,"changeRate":-0.0258,"turnoverRate":0.0162,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-11-18。","afterMarket":{"amount":0,"volume":0,"close":20.37,"buyVolume":0,"sellVolume":0,"time":1731656039464,"indexStatus":"已收盘 11-15 15:30:00","preClose":20.91}},"requestUrl":"/m/hq/s/688351/wiki","defaultTab":"wiki","newsList":[{"id":"2479455904","title":"微电生理-U大跌5.02% 6家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2479455904","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479455904?lang=zh_cn&edition=full","pubTime":"2024-10-29 13:19","pubTimestamp":1730179160,"startTime":"0","endTime":"0","summary":"10月29日,微电生理-U股价大幅下跌,截至13点19分,微电生理-U下跌5.02%,报20.42元/股,成交5976万元,换手率2.29%。此外,数据统计显示,近半年内6家券商给予增持建议,22家券商给予买入建议。主营业务及业绩微电生理-U公司主营业务为电生理介入诊疗与消融治疗领域创新医疗器械研发、生产和销售。最新财报显示,今年三季报,微电生理-U实现营业收入2.91亿元,同比增长23.21%,净利润为4,172.67万元,同比增长262.22%,基本每股收益为0.09元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029131945ab7d8c2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029131945ab7d8c2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688351"],"gpt_icon":0},{"id":"2479414275","title":"浦银国际证券:给予微电生理买入评级,目标价位27.9元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479414275","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479414275?lang=zh_cn&edition=full","pubTime":"2024-10-29 11:56","pubTimestamp":1730174180,"startTime":"0","endTime":"0","summary":"浦银国际证券有限公司胡泽宇,阳景近期对微电生理进行研究并发布了研究报告《3Q24国内业务有所承压,海外业务稳健增长》,本报告对微电生理给出买入评级,认为其目标价位为27.90元,当前股价为20.62元,预期上涨幅度为35.31%。维持“买入”评级及目标价人民币27.9元。最新盈利预测明细如下:该股最近90天内共有18家机构给出评级,买入评级14家,增持评级4家;过去90天内机构目标均价为27.39。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102900018882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688351","161027"],"gpt_icon":0},{"id":"2479115184","title":"浦银国际证券给予微电生理买入评级,3Q24国内业务有所承压,海外业务稳健增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2479115184","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479115184?lang=zh_cn&edition=full","pubTime":"2024-10-29 11:32","pubTimestamp":1730172720,"startTime":"0","endTime":"0","summary":"浦银国际证券10月29日发布研报称,给予微电生理(688351.SH,最新价:20.72元)买入评级。评级理由主要包括:1)3Q24收入因国内业务承压有所下滑,净利在降本控费下实现高增长;2)国内行业反腐对三维手术量造成影响,海外收入稳健增长;3)研发管线顺利推进。风险提示:政策风险、电生理手术量及核心产品销售增速不及预期。AI点评:微电生理近一个月获得5份券商研报关注,买入4家,平均目标价为27.9元,与最新价20.72元相比,高7.18元,目标均价涨幅34.65%。(文章来源:每日经济新闻)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029113947a1f3dec3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029113947a1f3dec3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["161027","688351"],"gpt_icon":0},{"id":"2478128634","title":"太平洋给予微电生理买入评级,微电生理点评报告:集采加速产品放量,脉冲消融进展顺利","url":"https://stock-news.laohu8.com/highlight/detail?id=2478128634","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478128634?lang=zh_cn&edition=full","pubTime":"2024-10-28 13:37","pubTimestamp":1730093820,"startTime":"0","endTime":"0","summary":"太平洋10月28日发布研报称,给予微电生理(688351.SH)买入评级。评级理由主要包括:1)公司产品集采进展顺利,叠加新品认可度提升,有望助力业绩增长;2)公司积极推进PFA项目研发进度,自研PFA进入特别审查程序;3)公司降本增效成果显著,整体净利率提升明显。风险提示:创新技术与产品的研发风险,核心技术人才流失风险,经营渠道管理风险,产品质量及潜在责任风险,市场竞争风险。AI点评:微电生理近一个月获得3份券商研报关注,买入2家。(文章来源:每日经济新闻)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028134305a1f0b1ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028134305a1f0b1ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688351","601099"],"gpt_icon":0},{"id":"2478412832","title":"太平洋:给予微电生理买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2478412832","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478412832?lang=zh_cn&edition=full","pubTime":"2024-10-28 13:35","pubTimestamp":1730093730,"startTime":"0","endTime":"0","summary":"太平洋证券股份有限公司谭紫媚近期对微电生理进行研究并发布了研究报告《微电生理点评报告:集采加速产品放量,脉冲消融进展顺利》,本报告对微电生理给出买入评级,当前股价为21.47元。维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有17家机构给出评级,买入评级13家,增持评级4家;过去90天内机构目标均价为27.39。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102800012400.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688351","601099"],"gpt_icon":0},{"id":"2478609448","title":"中邮证券:给予微电生理买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2478609448","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478609448?lang=zh_cn&edition=full","pubTime":"2024-10-25 17:39","pubTimestamp":1729849198,"startTime":"0","endTime":"0","summary":"中邮证券有限责任公司蔡明子,陈峻近期对微电生理进行研究并发布了研究报告《新产品增量明显,公司净利率显著提升》,本报告对微电生理给出买入评级,当前股价为21.46元。 公司前三季度国内压力导管手术量超过3000例。我们看好公司未来在电生理领域的发展前景,维持“买入评级”。最新盈利预测明细如下:该股最近90天内共有17家机构给出评级,买入评级13家,增持评级4家;过去90天内机构目标均价为27.39。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500032275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","688351"],"gpt_icon":0},{"id":"2478619905","title":"【机构调研记录】汇添富基金调研甘源食品、微电生理等6只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2478619905","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478619905?lang=zh_cn&edition=full","pubTime":"2024-10-25 08:04","pubTimestamp":1729814682,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及10月24日披露的机构调研信息,汇添富基金近期对6家上市公司进行了调研,相关名单如下:1)甘源食品 个股亮点:公司建立了完善的营销渠道,搭建了线下线上相融合的全渠道平台。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500007606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","002991","BK0251","688351"],"gpt_icon":0},{"id":"2478061993","title":"【机构调研记录】新华基金调研微电生理","url":"https://stock-news.laohu8.com/highlight/detail?id=2478061993","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478061993?lang=zh_cn&edition=full","pubTime":"2024-10-25 08:04","pubTimestamp":1729814671,"startTime":"0","endTime":"0","summary":"新华基金成立于2004年,截至目前,资产管理规模558.6亿元,排名79/207;资产管理规模347.45亿元,排名89/207;管理公募基金数78只,排名76/207;旗下公募基金经理16人,排名83/207。旗下最近一年表现最佳的公募基金产品为新华利率债债券E,最新单位净值为1.96,近一年增长92.26%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500007593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688351","BK0251"],"gpt_icon":0},{"id":"2478768676","title":"微电生理-U:配送商调整及收入延期确认影响短期业绩 高端产品放量可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2478768676","media":"国盛证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478768676?lang=zh_cn&edition=full","pubTime":"2024-10-25 00:00","pubTimestamp":1729785600,"startTime":"0","endTime":"0","summary":"微电生理发布2024 年三季度报告。期间费用率下降驱动利润端增速好于收入端,扣非端差异主要系政府补助影响。Q3 收入波动,主要系国内部分区域更换配送商及海外部分项目收入确认延后的影响。TrueForce压力导管销量优异,成为上半年销售额占比最高的产品。2024Q3 公司三维电生理手术量超6000 台,其中国内约5000 台,国外约1000 台,Q1-Q3 海外手术量同比增长高于国内。压力导管使用量逐月环比递增,Q1-Q3 国内手术量超3000 例,海外超1000 例,其中三分之一用于房颤治疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102515264195bd564a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102515264195bd564a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688351","BK0251"],"gpt_icon":0},{"id":"2477750395","title":"微电生理:10月22日接受机构调研,华泰证券、富国基金等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2477750395","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477750395?lang=zh_cn&edition=full","pubTime":"2024-10-24 16:54","pubTimestamp":1729760094,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年10月24日微电生理发布公告称公司于2024年10月22日接受机构调研,华泰证券、富国基金、中信建投、兴业证券、招商证券、华福证券、国海证券、汇添富基金、新华基金、中信建投基金参与。2024Q3,公司实现营业收入9250万元,较Q2略有下滑,其中海外营收同比增长超过20%,主要系国内部分区域更换配送商及海外部分项目收入确认延后因素的影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102400026988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1328615791.USD","688351","LU1781817850.SGD","LU1064131003.USD","BK0276","BK0183","LU1934453819.USD","LU1979443071.USD","LU1064130708.USD","LU2148510915.USD","BK0251","601688","LU1580142542.USD","BK0028","BK0188","BK0012"],"gpt_icon":0},{"id":"2477541499","title":"微电生理-U大幅上涨 北京发布医疗器械产业提质升级行动计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2477541499","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477541499?lang=zh_cn&edition=full","pubTime":"2024-10-24 11:16","pubTimestamp":1729739769,"startTime":"0","endTime":"0","summary":"通告显示,近期,广东省药品监督管理局组织开展医疗器械生产企业监督检查,发现深圳市安保医疗科技股份有限公司质量管理体系存在严重缺陷,不符合《医疗器械生产质量管理规范》相关规定,广东省药品监督管理局已依法采取责令暂停生产的控制措施。北京市即将发布《北京市医疗器械产业提质升级行动计划》。主营业务及业绩微电生理-U公司主营业务为电生理介入诊疗与消融治疗领域创新医疗器械研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024111716ab6eefea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024111716ab6eefea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688351","159883","BK0251"],"gpt_icon":0},{"id":"2477740588","title":"华安证券:给予微电生理买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2477740588","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477740588?lang=zh_cn&edition=full","pubTime":"2024-10-23 19:25","pubTimestamp":1729682714,"startTime":"0","endTime":"0","summary":"华安证券股份有限公司谭国超,李婵近期对微电生理进行研究并发布了研究报告《2024Q3房颤布局加速,公司利润端表现亮眼》,本报告对微电生理给出买入评级,当前股价为20.38元。最新盈利预测明细如下:该股最近90天内共有17家机构给出评级,买入评级13家,增持评级4家;过去90天内机构目标均价为27.39。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102300032609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600909","688351"],"gpt_icon":0},{"id":"2477375778","title":"微电生理-U10月23日主力资金流入168万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2477375778","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477375778?lang=zh_cn&edition=full","pubTime":"2024-10-23 15:18","pubTimestamp":1729667897,"startTime":"0","endTime":"0","summary":"10月23日, 微电生理-U股价涨0.20%,报收20.38元,成交金额1.51亿元,换手率5.93%,振幅4.67%,量比1.23。微电生理-U今日主力资金净流入168万元,连续3日净流入,上一交易日主力净流入251万元,今日环比减少33.07%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为71.43%,平均涨幅为4.21%。该股近5个交易日上涨11.79%,主力资金累计净流入1275万元;近20日主力资金累计净流出3560万元,其中净流出天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410231528139f58687c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410231528139f58687c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688351","BK0251"],"gpt_icon":0},{"id":"2477392452","title":"微电生理(688351)2024年三季报简析:营收净利润同比双双增长,公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2477392452","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477392452?lang=zh_cn&edition=full","pubTime":"2024-10-23 06:03","pubTimestamp":1729634626,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期微电生理发布2024年三季报。截至本报告期末,公司营业总收入2.91亿元,同比上升23.21%,归母净利润4172.67万元,同比上升262.22%。本报告期微电生理公司应收账款体量较大,当期应收账款占最新年报归母净利润比达894.16%。2024H1,国内营业收入增长超过45%,主要得益于产品结构进一步优化,高净值的迭代产品及压力导管类等新品增速较快。在国外市场,2024H1房颤手术占三维手术量的比达到25%,预计全年压力导管手术量超过1000例。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102300004629.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688351"],"gpt_icon":0},{"id":"2477341388","title":"微电生理三季报归属净利润同比大涨262.22%,三同行业绩报喜","url":"https://stock-news.laohu8.com/highlight/detail?id=2477341388","media":"金色光","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477341388?lang=zh_cn&edition=full","pubTime":"2024-10-22 17:20","pubTimestamp":1729588833,"startTime":"0","endTime":"0","summary":"近日,上市公司微电生理披露2024年三季报,前三季度公司归属净利润为4172.67万元,同比大涨262.22%。2024年前9个月,健帆生物经营活动产生的现金流量净额为8.72亿元,同比上涨47.72%,涨幅明显。此外,仅看第三季度,当季健帆生物营收和归属净利润分别为7亿元和2.39亿元,分别同比上涨47.74%和63.62%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102217240895baef77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102217240895baef77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688351"],"gpt_icon":0},{"id":"2477814878","title":"平安证券:给予微电生理增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2477814878","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477814878?lang=zh_cn&edition=full","pubTime":"2024-10-22 11:52","pubTimestamp":1729569137,"startTime":"0","endTime":"0","summary":"平安证券股份有限公司叶寅,倪亦道,裴晓鹏近期对微电生理进行研究并发布了研究报告《公司业绩保持稳健增长,经营质量不断提升》,本报告对微电生理给出增持评级,当前股价为20.8元。 公司不断推进产品迭代研发,有望充分受益于行业增长,长期发展可期。 维持“推荐”评级。最新盈利预测明细如下:该股最近90天内共有16家机构给出评级,买入评级12家,增持评级4家;过去90天内机构目标均价为28.02。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102200016163.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","688351"],"gpt_icon":0},{"id":"2477995288","title":"图解微电生理三季报:第三季度单季净利润同比增163.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477995288","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477995288?lang=zh_cn&edition=full","pubTime":"2024-10-22 00:32","pubTimestamp":1729528376,"startTime":"0","endTime":"0","summary":"证券之星消息,微电生理2024年三季报显示,公司主营收入2.91亿元,同比上升23.21%;归母净利润4172.67万元,同比上升262.22%;扣非净利润-75.25万元,同比上升95.69%;其中2024年第三季度,公司单季度主营收入9250.15万元,同比下降1.54%;单季度归母净利润2471.4万元,同比上升163.92%;单季度扣非净利润-167.42万元,同比上升67.09%;负债率7.35%,投资收益664.82万元,财务费用-167.83万元,毛利率58.79%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102200000138.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688351"],"gpt_icon":0},{"id":"2477782928","title":"微电生理:公司业绩保持稳健增长 经营质量不断提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2477782928","media":"平安证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477782928?lang=zh_cn&edition=full","pubTime":"2024-10-22 00:00","pubTimestamp":1729526400,"startTime":"0","endTime":"0","summary":"公司前三季度收入端保持稳健增长趋势,单Q3收入有所下滑预计主要因为国内发货节奏影响、海外部分回款变慢,影响了单季度收入增长趋势,全年来看,随着公司手术量不断增长,全年收入有望保持快速增长趋势。国内电生理治疗渗透率仍低,行业有望保持快速增长趋势,公司产品布局完备有望受益于行业增长,此外,公司仍不断推进产品迭代研发,保障长期增长。维持“推荐”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410221021249f551bbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410221021249f551bbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688351"],"gpt_icon":0},{"id":"2477382174","title":"微电生理:多项创新产品顺利推进 公司净利润端表现出色","url":"https://stock-news.laohu8.com/highlight/detail?id=2477382174","media":"广发证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477382174?lang=zh_cn&edition=full","pubTime":"2024-10-22 00:00","pubTimestamp":1729526400,"startTime":"0","endTime":"0","summary":"根据公司微信公众号,截止24H1,公司的全球三维手术量累计突破7 万例。国内市场,TrueForce压力导管入院速度相对加快,上市以来已完成近3000 例射频消融手术;IceMagic冷冻消融产品已完成近30 个省份的挂网。国际市场,公司的三维手术量实现快速增长,累计覆盖36 个国家和地区。多项创新产品顺利推进。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410221821269f5661b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410221821269f5661b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688351"],"gpt_icon":0},{"id":"2477834660","title":"微电生理(688351.SH)发布前三季度业绩,净利润4172.67万元,同比增长262.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477834660","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477834660?lang=zh_cn&edition=full","pubTime":"2024-10-21 17:45","pubTimestamp":1729503959,"startTime":"0","endTime":"0","summary":"智通财经APP讯,微电生理(688351.SH)发布2024年第三季度报告,公司前三季度营业收入2.91亿元,同比增长23.21%;归属于上市公司股东的净利润4172.67万元,同比增长262.22%;归属于上市公司股东的扣除非经常性损益的净亏损75.25万元;基本每股收益0.0887元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1196835.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688351"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-08-31","address":"上海市浦东新区周浦镇天雄路588弄1-28号第28幢","stockEarnings":[{"period":"1week","weight":-0.0472},{"period":"1month","weight":0.1174},{"period":"3month","weight":-0.1174},{"period":"6month","weight":-0.1974},{"period":"1year","weight":-0.0943},{"period":"ytd","weight":-0.2058}],"companyName":"上海微创电生理医疗科技股份有限公司","boardCode":"AI0035","perCapita":"18585股","boardName":"专用设备制造业","registeredCapital":"47060万元","compareEarnings":[{"period":"1week","weight":-0.0352},{"period":"1month","weight":0.0399},{"period":"3month","weight":0.1567},{"period":"6month","weight":0.056},{"period":"1year","weight":0.0917},{"period":"ytd","weight":0.1196}],"survey":" 上海微创电生理医疗科技股份有限公司的主营业务是电生理介入诊疗与消融治疗领域创新医疗器械研发、生产和销售,提供具备全球竞争力的“以精准介入导航为核心的诊断及消融治疗一体化解决方案”。公司主要产品包括心脏电生理设备与心脏电生理耗材等。公司合计取得已授权境内外专利120项,其中发明专利69项。公司始终关注科技成果与产业应用的深度融合,先后承担了国家级和省市级科研课题17项。2022年公司获得国家级专精特新“小巨人”企业认定称号。","serverTime":1731723448596,"listedPrice":16.51,"stockholders":"6718人(较上一季度增加21.09%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"微电生理(688351)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供微电生理(688351)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"微电生理,688351,微电生理股票,微电生理股票老虎,微电生理股票老虎国际,微电生理行情,微电生理股票行情,微电生理股价,微电生理股市,微电生理股票价格,微电生理股票交易,微电生理股票购买,微电生理股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"微电生理(688351)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供微电生理(688351)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}